FAL
NVS icon

Focused Alpha LLC’s Novartis NVS Stock Holding History

Focused Alpha LLC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+1,484
New +$222K 0.06% 247

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Focused Alpha LLC's NVS Position: Q2 2026 in Review

Focused Alpha LLC opened a new position in Novartis (NVS) in Q2 2026: 1,484 shares worth $233K. The stake represents 0.06% of the portfolio and ranks #247 among its holdings.

1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Focused Alpha LLC held 1,484 shares of Novartis worth $233K as of Q2 2026.
  • Novartis was a new Focused Alpha LLC position in Q2 2026.
  • Novartis made up 0.06% of Focused Alpha LLC's portfolio in Q2 2026, its #247 holding.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.